Position | Company | Period |
---|---|---|
Chief Executive Officer, Director | Avadel Pharmaceuticals PLC | 22 juin 2012 - 30 décembre 2018 |
Chief Executive Officer | Avadel Pharmaceuticals PLC | 13 mars 2012 - 22 juin 2012 |
Rechercher
Date de notification | Date de transaction | A/V Type de transaction |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur totale | Détails | |
---|---|---|---|---|---|---|---|---|
2018-08-14 | 2018-08-10 |
Avadel Pharmaceuticals PLC
(AVDL)
|
V Vente |
16 297
-6.1%
4,9179 953 USD |
16 297 -6.1% | 4,91 | 79 953 USD | |
2018-06-27 | 2018-06-26 |
Avadel Pharmaceuticals PLC
(AVDL)
|
A Achat |
2 500
+1.0%
6,0415 100 USD |
2 500 +1.0% | 6,04 | 15 100 USD | |
2016-09-07 | 2016-09-02 |
Avadel Pharmaceuticals PLC
(AVDL)
|
A Achat |
2 000
+1.1%
14,1228 240 USD |
2 000 +1.1% | 14,12 | 28 240 USD | |
2016-05-16 | 2016-05-12 |
Avadel Pharmaceuticals PLC
(AVDL)
|
A Achat |
5 000
+3.9%
8,8444 200 USD |
5 000 +3.9% | 8,84 | 44 200 USD | |
2016-03-21 | 2016-03-18 |
Avadel Pharmaceuticals PLC
(AVDL)
|
A Achat |
5 000
+4.0%
11,0455 220 USD |
5 000 +4.0% | 11,04 | 55 220 USD | |
2016-03-16 | 2016-03-14 |
Avadel Pharmaceuticals PLC
(AVDL)
|
A Achat |
10 000
+8.8%
9,7497 350 USD |
10 000 +8.8% | 9,74 | 97 350 USD |